摘要:
In an industrial two-layer fabric, either one of an upper side binding yarn and a lower surface binding yarn constituting a pair to be woven with an upper surface weft and a lower side weft passes under one lower surface weft and then passes over a plurality of lower surface wefts. A warp on one adjacent side of the one of the upper and lower surface binding yarns has a similar design thereto and passes over and under the same lower surface wefts. The design of a set of the two warps adjacent to each other is shifted and arranged one after another to form a complete design of the lower surface fabric and a lower surface weft has a design in which the weft passes over two successive warps and then passes under a plurality of warps to form a long crimp on the lower surface.
摘要:
In a repeating unit of a two-layer fabric, a first upper surface side warp forms a first upper surface side warp design. A second upper surface side warp forms a latent portion in which the second upper surface side warp passes between the two layers of the fabric. A first lower warp binding yarn and a second lower warp binding yarn form first and second knuckles respectively by passing over one or two upper surface side wefts at a position not adjacent to two knuckles of the second upper surface side warp in the latent portion. The first and second knuckles are formed at different positions. The first lower warp binding yarn, second upper surface side warp and second lower warp binding yarn cooperatively form a second upper surface side warp design similar to the first upper surface side warp design.
摘要:
An industrial two-layer fabric comprises an upper layer fabric having upper surface side warps and upper surface side wefts and a lower layer fabric having lower surface side warps and lower surface side wefts. The upper layer fabric and the lower layer fabric are bound at least one spot in a repeating unit where an upper surface side warp weaves a lower surface side weft without weaving an upper surface side weft which should have been woven by the upper surface side warp based on the fabric structure, and where a lower surface side warp weaves the upper surface side weft which should have been woven by the upper surface side warp, without weaving the lower surface side weft which should have been woven by the lower surface side warp.
摘要:
Two-cistronic Met-IGF-I expression vector, in which the first cistron encodes a protective peptide with a molecular weight of about 500-50,000 and the second cistron encodes IGF-I, was provided. Also provided is a process for preparing Met-IGF-I, which comprises transforming E. coli with said vector and growing the resultant transformant, followed by the lysis of the cell culture and isolation of Met-IGF-I.
摘要:
IGF-I fused with a protective peptide, in which the protective peptide is a protein peptide and is used for the protection of IGF-I from degradation by protease in cells of E. coli is disclosed. Also disclosed are genes coding for the fused IGF-I's, plasmids containing the genes, and E. coli microorganisms transformed with the plasmids.
摘要:
This invention provides a benezene-fused heterocyclic compound of the formula: ##STR1## wherein R.sup.1 is halogen, nitro, amino, hydroxy, lower alkyl, lower alkoxy substituted by carboxy or protected carboxy, acylamino which may have lower alkyl on the amino moiety, or aryloxy which may have halogen,R.sup.2 is hydrogen or halogen,X is --O-- or ##STR2## in which R.sup.3 is hydrogen, lower alkyl or acyl and A is a group of the formula: ##STR3## in which R.sup.4 is hydrogen, lower, alkenyl, lower alkynyl or alkyl which may have suitable substituent(s) selected from the groups consisting of hydroxy, acyl, lower alkoxy, di(lower)alkylamino, carboxy, protected carboxy and aryl; orR.sup.1 is hydrogen or lower alkoxy,R.sup.2 is hydrogen,X is ##STR4## in which R.sub.a.sup.3 is lower alkanoyl and A is a group of the formula: ##STR5## and pharmaceutically acceptable salts thereof. This compound possesses diuretic activity, uricosuric activity and vasodilative activity and are useful as a diuretic agent, uricosuric agent and anti-hypertensive agent. The invention further relates to processes for the preparation of this compound and pharmaceutical composition comprising compound of the above formula.
摘要:
This invention concerns antibiotic cephalosporins of the formula ##STR1## wherein R.sup.1 is amino or protected amino; R.sup.2 is halogen; R.sup.3 is alkyl; and R.sup.6 is carboxy or protected carboxy.
摘要:
Compounds of the formula ##STR1## are disclosed whereinR.sup.1 is hydrogen or lower alkyl, one of R.sup.2 and R.sup.3 is mono (or di)-nitroxy(lower)alkyl and the otherR.sup.2 and R.sup.3 is hydrogen and pharmaceutically acceptable salts thereof.Also disclosed are vasodilating compositions containing the above.
摘要:
The present invention relates to novel quinazolinone derivatives and pharmaceutically acceptable salts thereof. More particularly, it relates to novel quinazolinone derivatives and pharmaceutically acceptable salts thereof which have antiallergic activities, to processes for the preparation thereof, to pharmaceutical composition comprising the same, and to a method of using the same therapeutically in the treatment of allergic symptoms in human being and animals.
摘要:
New fused imidazole compounds of the formula: ##STR1## wherein A is lower alkylene,R.sup.1 is hydrogen, lower alkyl, lower alkoxy or halogen,R.sup.2 is hydrogen, lower alkyl, cyclo(lower)alkyl, pyridyl, ar(lower)alkyl which may be substituted with halogen, or aryl which may be substituted with lower alkyl, lower alkoxy, hydroxy or halogen,R.sup.3 is N-containing unsaturated heterocyclic group which may be substituted with lower alkyl or amino, andY is .dbd.C-- or .dbd.N--,and pharmaceutically acceptable salts thereof, and processes for preparation thereof and pharmaceutical composition comprising the same.These derivatives and salts thereof are useful as antiulcer agents.
摘要翻译:其中A为低级亚烷基,R 1为氢,低级烷基,低级烷氧基或卤素,R 2为氢,低级烷基,环(低级)烷基,吡啶基,Ar(低级)烷基, 可以被卤素取代,或可以被低级烷基,低级烷氧基,羟基或卤素取代的芳基,R3是可被低级烷基或氨基取代的含N不饱和杂环基,Y是=或= N - 及其药学上可接受的盐,及其制备方法和包含其的药物组合物。 这些衍生物和其盐可用作抗溃疡剂。